290 related articles for article (PubMed ID: 11190204)
1. International harmonization of bioequivalence studies and issues shared in common.
Nakai K; Fujita M; Ogata H
Yakugaku Zasshi; 2000 Nov; 120(11):1193-200. PubMed ID: 11190204
[TBL] [Abstract][Full Text] [Related]
2. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the switchability of generic products.
Karalis V; Bialer M; Macheras P
Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence and other unresolved issues in generic drug substitution.
Meredith P
Clin Ther; 2003 Nov; 25(11):2875-90. PubMed ID: 14693311
[TBL] [Abstract][Full Text] [Related]
5. Global Harmonization of Comparator Products for Bioequivalence Studies.
Gwaza L; Gordon J; Leufkens H; Stahl M; García-Arieta A
AAPS J; 2017 May; 19(3):603-606. PubMed ID: 28265983
[TBL] [Abstract][Full Text] [Related]
6. [Bioequivalence studies of pharmaceutical preparations].
Vetchý D; Frýbortová K; Rabisková M; Danecková H
Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
[TBL] [Abstract][Full Text] [Related]
7. [Trends in the quality evaluation of generic products and bioequivalence guidelines].
Yomota C
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2012; (130):1-12. PubMed ID: 23243982
[TBL] [Abstract][Full Text] [Related]
8. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
Dupont AG; Heller F
Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Considerations of Bioequivalence Studies for Oral Solid Dosage Forms in Japan.
Kuribayashi R; Takishita T; Mikami K
J Pharm Sci; 2016 Aug; 105(8):2270-7. PubMed ID: 27372551
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence requirements for generic products.
Nation RL; Sansom LN
Pharmacol Ther; 1994; 62(1-2):41-55. PubMed ID: 7991647
[TBL] [Abstract][Full Text] [Related]
11. Generics Substitution, Bioequivalence Standards, and International Oversight: Complex Issues Facing the FDA.
Bate R; Mathur A; Lever HM; Thakur D; Graedon J; Cooperman T; Mason P; Fox ER
Trends Pharmacol Sci; 2016 Mar; 37(3):184-191. PubMed ID: 26687297
[TBL] [Abstract][Full Text] [Related]
12. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
Meredith PA
Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
[TBL] [Abstract][Full Text] [Related]
13. Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence Studies.
Kajiwara E; Kamizato H; Shikano M
Ther Innov Regul Sci; 2021 Sep; 55(5):1096-1100. PubMed ID: 34097289
[TBL] [Abstract][Full Text] [Related]
14. Generic products of antiepileptic drugs (AEDs): is it an issue?
Bialer M
Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
[TBL] [Abstract][Full Text] [Related]
15. A review of the safety of generic drugs.
Dighe SV
Transplant Proc; 1999 May; 31(3A Suppl):23S-24S. PubMed ID: 10330955
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA).
Moeti L; Litedu M; Joubert J
Ther Innov Regul Sci; 2022 Sep; 56(5):822-838. PubMed ID: 35896784
[TBL] [Abstract][Full Text] [Related]
17. The transitivity of bioequivalence testing: potential for drift.
Anderson S; Hauck WW
Int J Clin Pharmacol Ther; 1996 Sep; 34(9):369-74. PubMed ID: 8880284
[TBL] [Abstract][Full Text] [Related]
18. Modernization and Strengthening of Bioequivalence Guidelines in Japan.
Kuribayashi R; Yamaguchi T; Takagi K
Clin Pharmacokinet; 2021 Feb; 60(2):145-151. PubMed ID: 33247363
[TBL] [Abstract][Full Text] [Related]
19. Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes.
Adams WP; Poochikian G; Taylor AS; Patel RM; Burke GP; Williams RL
J Aerosol Med; 1994; 7(2):119-34. PubMed ID: 10147277
[TBL] [Abstract][Full Text] [Related]
20. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
